Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Stoke Therapeutics (STOK) Return on Assets (2022 - 2025)

Stoke Therapeutics (STOK) has 4 years of Return on Assets data on record, last reported at 0.11% in Q3 2025.

  • For Q3 2025, Return on Assets rose 46.0% year-over-year to 0.11%; the TTM value through Sep 2025 reached 0.11%, up 46.0%, while the annual FY2024 figure was 0.36%, 8.0% up from the prior year.
  • Return on Assets reached 0.11% in Q3 2025 per STOK's latest filing, down from 0.13% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.15% in Q1 2025 and bottomed at 0.5% in Q1 2024.
  • Average Return on Assets over 4 years is 0.27%, with a median of 0.37% recorded in 2022.
  • Peak YoY movement for Return on Assets: decreased -13bps in 2024, then soared 65bps in 2025.
  • A 4-year view of Return on Assets shows it stood at 0.38% in 2022, then dropped by -18bps to 0.45% in 2023, then increased by 30bps to 0.32% in 2024, then surged by 134bps to 0.11% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Assets were 0.11% in Q3 2025, 0.13% in Q2 2025, and 0.15% in Q1 2025.